1)Sauaia A, Moore FA, Moore EE, et al:Early predictors of postinjury multiple organ failure. Arch Surg 129:39-45, 1994
2)Diaz JJ Jr, Dutton WD, Ott MM, et al:Eastern Association for the Surgery of Trauma:a review of the management of the open abdomen--part 2 “Management of the open abdomen”. J Trauma 71:502-512, 2011
3)Diaz JJ Jr, Cullinane DC, Dutton WD, et al:The management of the open abdomen in trauma and emergency general surgery:part 1-damage control. J Trauma 68:1425-1438, 2010
4)Gruen RL, Jurkovich GJ, McIntyre LK, et al:Patterns of errors contributing to trauma mortality:lessons learned from 2,594 deaths. Ann Surg 244:371-380, 2006
5)Wyrzykowski AD, Feliciano DV:Trauma damage control. in Feliciano DV MK, Moore EE(eds);Trauma, 7th ed. New York, McGraw-Hill, 2013, pp 725-746
6)Duchesne JC, McSwain NE Jr, Cotton BA, et al:Damage control resuscitation:the new face of damage control. J Trauma 69:976-990, 2010
7)MacLeod JB, Lynn M, McKenney MG, et al:Early coagulopathy predicts mortality in trauma. J Trauma 55:39-44, 2003
8)Brohi K:Diagnosis and management of coagulopathy after major trauma. Br J Surg 96:963-964, 2009
9)Geeraedts LM Jr, Demiral H, Schaap NP, et al:‘Blind' transfusion of blood products in exsanguinating trauma patients. Resuscitation 73:382-388, 2007
10)Holcomb JB, Jenkins D, Rhee P, et al:Damage control resuscitation:directly addressing the early coagulopathy of trauma. J Trauma 62:307-310, 2007
11)Brohi K, Singh J, Heron M, et al:Acute traumatic coagulopathy. J Trauma 54:1127-1130, 2003
12)Maegele M, Lefering R, Yucel N, et al:Early coagulopathy in multiple injury:an analysis from the German Trauma Registry on 8724 patients. Injury 38:298-304, 2007
13)Frith D, Goslings JC, Gaarder C, et al:Definition and drivers of acute traumatic coagulopathy:clinical and experimental investigations. J Thromb Haemost 8:1919-1925, 2010
14)Kutcher ME, Kornblith LZ, Narayan R, et al:A paradigm shift in trauma resuscitation:evaluation of evolving massive transfusion practices. JAMA Surg 148:834-840, 2013
15)Davenport R, Khan S:Management of major trauma haemorrhage:treatment priorities and controversies. Br J Haematol 155:537-548, 2011
16)丸藤 哲,亀上 隆,澤村 淳,他:外傷後にみられる血液凝固線溶系の変化—新しい考え方と治療方法.日救急医会誌17:629-644,2001
17)Gando S:Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost 27:585-592, 2001
18)久志本成樹:外傷とDIC.丸山征郎(編);DIC診療ガイドブック.メディカルレビュー社,2009,pp 104-116
19)久志本成樹:急性期DIC診断基準によるDIC症例の臨床経過.日外感染症会誌7:115-125,2010
20)Tremblay LN, Feliciano DV, Schmidt J, et al:Skin only or silo closure in the critically ill patient with an open abdomen. Am J Surg 182:670-675, 2001
):the ninth edition. J Trauma Acute Care Surg 74:1363-1366, 2013
22)Borgman MA, Spinella PC, Perkins JG, et al:The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 63:805-813, 2007
23)Murad MH, Stubbs JR, Gandhi MJ, et al:The effect of plasma transfusion on morbidity and mortality:a systematic review and meta-analysis. Transfusion 50:1370-1383, 2010
24)Spahn DR, Bouillon B, Cerny V, et al:Management of bleeding and coagulopathy following major trauma:an updated European guideline. Crit Care 17:R76, 2013
25)Duchesne JC, Islam TM, Stuke L, et al:Hemostatic resuscitation during surgery improves survival in patients with traumatic-induced coagulopathy. J Trauma 67:33-37;discussion 37-39, 2009
26)Holcomb JB, Wade CE, Michalek JE, et al:Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 248:447-458, 2008
27)Asensio JA, McDuffie L, Petrone P, et al:Reliable variables in the exsanguinated patient which indicate damage control and predict outcome. Am J Surg 182:743-751, 2001
28)Jurkovich GJ, Greiser WB, Luterman A, et al:Hypothermia in trauma victims:an ominous predictor of survival. J Trauma 27:1019-1024, 1987
29)Toulon P, Ozier Y, Ankri A, et al:Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 101:394-401, 2009
30)Davenport R, Manson J, De'Ath H, et al:Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 39:2652-2658, 2011
31)Mann KG, Butenas S, Brummel K:The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 23:17-25, 2003
32)Tripodi A, Chantarangkul V, Mannucci PM:Acquired coagulation disorders:revisited using global coagulation/anticoagulation testing. Br J Haematol 147:77-82, 2009
33)Fries D, Martini WZ:Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 105:116-121, 2010
34)Aoki N, Harpel PC:Inhibitors of the fibrinolytic enzyme system. Semin Thromb Hemost 10:24-41, 1984
35)Francis CW, Marder, VJ:Physiologic regulation and pathologic disorders of fibrinolysis. in Colman RW, Hirsh J, Marder VJ, et al(eds);Hemostasis and Thrombosis:Basic Principles and Clinical Practice, 3rd ed. Philadelphia, J.B.Lippincott Co., 1994, pp 1076-1103
36)Kushimoto S, Shibata Y, Yamamoto Y:Implications of fibrinogenolysis in patients with closed head injury. J Neurotrauma 20:357-363, 2003
37)Sawamura A, Hayakawa M, Gando S, et al:Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res 124:608-613, 2009
38)Schöchl H, Nienaber U, Hofer G, et al:Goal-directed coagulation management of major trauma patients using thromboelastometry(ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 14:R55, 2010
39)Asehnoune K, Faraoni D, Brohi K:What's new in management of traumatic coagulopathy? Intensive Care Med 40:1727-1730, 2014
40)Gruen RL, Brohi K, Schreiber M, et al:Haemorrhage control in severely injured patients. Lancet 380:1099-1108, 2012
41)Curry N, Hopewell S, Doree C, et al:The acute management of trauma hemorrhage:a systematic review of randomized controlled trials. Crit Care 15:R92, 2011
42)Theusinger OM, Spahn DR, Ganter MT:Transfusion in trauma:why and how should we change our current practice? Curr Opin Anaesthesiol 22:305-312, 2009
43)Duchesne JC, Hunt JP, Wahl G, et al:Review of current blood transfusions strategies in a mature level I trauma center:were we wrong for the last 60 years? J Trauma 65:272-276;discussion 276-278, 2008
44)Fraga GP, Bansal V, Coimbra R:Transfusion of blood products in trauma:an update. J Emerg Med 39:253-260, 2010
45)Sperry JL, Ochoa JB, Gunn SR, et al:An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma 65:986-993, 2008
46)Holcomb JB, del Junco DJ, Fox EE, et al:The prospective, observational, multicenter, major trauma transfusion(PROMMTT)study:comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 148:127-136, 2013
47)Radwan ZA, Bai Y, Matijevic N, et al:An emergency department thawed plasma protocol for severely injured patients. JAMA Surg 148:170-175, 2013
48)Holcomb JB, Tilley BC, Baraniuk S, et al:Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma:the PROPPR randomized clinical trial. JAMA 313:471-482, 2015
49)Hallet J, Lauzier F, Mailloux O, et al:The use of higher platelet:RBC transfusion ratio in the acute phase of trauma resuscitation:a systematic review. Crit Care Med 41:2800-2811, 2013
50)Snyder CW, Weinberg JA, McGwin G Jr, et al:The relationship of blood product ratio to mortality:survival benefit or survival bias? J Trauma 66:358-362;discussion 362-364, 2009
51)Bickell WH, Wall MJ Jr, Pepe PE, et al:Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 331:1105-1109, 1994
52)Dutton RP, Mackenzie CF, Scalea TM:Hypotensive resuscitation during active hemorrhage:impact on in-hospital mortality. J Trauma 52:1141-1146, 2002
53)Morrison CA, Carrick MM, Norman MA, et al:Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock:preliminary results of a randomized controlled trial. J Trauma 70:652-663, 2011
54)Hiippala ST, Myllyla GJ, Vahtera EM:Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81:360-365, 1995
55)Charbit B, Mandelbrot L, Samain E, et al:The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5:266-273, 2007
56)Spahn DR, Cerny V, Coats TJ, et al:Management of bleeding following major trauma:a European guideline. Crit Care 11:R17, 2007
57)Thomas D, Wee M, Clyburn P, et al:Blood transfusion and the anaesthetist:management of massive haemorrhage. Anaesthesia 65:1153-1161, 2010
58)Bell SF, Rayment R, Collins PW, et al:The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth 19:218-223, 2010
59)Gerlach R, Tolle F, Raabe A, et al:Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity:implications of a prospective study. Stroke 33:1618-1623, 2002
60)Blome M, Isgro F, Kiessling AH, et al:Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 93:1101-1107, 2005
61)Ucar HI, Oc M, Tok M, et al:Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery. Heart Surg Forum 10:E392-396, 2007
62)Moganasundram S, Hunt BJ, Sykes K, et al:The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children. Anesth Analg 110:995-1002, 2010
63)Aubron C, Reade MC, Fraser JF, et al:Efficacy and safety of fibrinogen concentrate in trauma patients--a systematic review. J Crit Care 29:471 e11-17, 2014
64)Levy JH, Goodnough LT:How I use fibrinogen replacement therapy in acquired bleeding. Blood 125:1387-1393, 2015
65)Wikkelso A, Lunde J, Johansen M, et al:Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev 8:CD008864, 2013
66)Shakur H, Roberts I, Bautista R, et al:Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage(CRASH-2):a randomised, placebo-controlled trial. Lancet 376:23-32, 2010
67)Roberts I, Shakur H, Afolabi A, et al:The importance of early treatment with tranexamic acid in bleeding trauma patients:an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377:1096-1101, 1101. e1-2, 2011
68)Roberts I, Perel P, Prieto-Merino D, et al:Effect of tranexamic acid on mortality in patients with traumatic bleeding:prespecified analysis of data from randomised controlled trial. BMJ 345:e5839, 2012
69)Raeburn CD, Moore EE, Biffl WL, et al:The abdominal compartment syndrome is a morbid complication of postinjury damage control surgery. Am J Surg 182:542-546, 2001
70)Nagy KK, Fildes JJ, Mahr C, et al:Experience with three prosthetic materials in temporary abdominal wall closure. Am Surg 62:331-335, 1996
71)Offner PJ, de Souza AL, Moore EE, et al:Avoidance of abdominal compartment syndrome in damage-control laparotomy after trauma. Arch Surg 136:676-681, 2001